BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12804331)

  • 1. The psychosocial impact of the implantable cardioverter defibrillator: a meta-analytic review.
    Burke JL; Hallas CN; Clark-Carter D; White D; Connelly D
    Br J Health Psychol; 2003 May; 8(Pt 2):165-78. PubMed ID: 12804331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recipients' of implanted cardioverter-defibrillators actual and perceived adaptation: a review of the literature.
    Zayac S; Finch N
    J Am Acad Nurse Pract; 2009 Oct; 21(10):549-56. PubMed ID: 19796289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable cardioverter defibrillator (ICD) in children.
    Eicken A; Kolb C; Lange S; Brodherr-Heberlein S; Zrenner B; Schreiber C; Hess J
    Int J Cardiol; 2006 Feb; 107(1):30-5. PubMed ID: 16337494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiological and psychosocial status of patients with malignant ventricular arrhythmias before implantation of a cardioverter defibrillator. First results from the German Austrian ICD Multicenter Study (GAIMS)].
    Herrmann-Lingen C; Fritzsche K; Kanwischer H; Drinkmann A; Rabung S; Bergmann G;
    Psychother Psychosom Med Psychol; 2004 Aug; 54(8):308-19. PubMed ID: 15284942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The implantable cardioverter defibrillator: its history, current psychological impact and future.
    Matchett M; Sears SF; Hazelton G; Kirian K; Wilson E; Nekkanti R
    Expert Rev Med Devices; 2009 Jan; 6(1):43-50. PubMed ID: 19105779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death.
    Lau EW; Griffith MJ; Pathmanathan RK; Ng GA; Clune MM; Cooper J; Marshall HJ; Forsey PR; Stafford PJ; Gray RG; Skehan JD; Garratt CJ
    Europace; 2004 Jul; 6(4):257-66. PubMed ID: 15172648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ICD: a qualitative study of patient experience the first year after implantation.
    Kamphuis HC; Verhoeven NW; Leeuw R; Derksen R; Hauer RN; Winnubst JA
    J Clin Nurs; 2004 Nov; 13(8):1008-16. PubMed ID: 15533107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
    Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
    Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable cardioverter defibrillators: physical and psychosocial outcomes.
    Craney JM; Mandle CL; Munro BH; Rankin S
    Am J Crit Care; 1997 Nov; 6(6):445-51. PubMed ID: 9354222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychological and clinical problems in young adults with implantable cardioverter-defibrillators.
    Wójcicka M; Lewandowski M; Smolis-Bak E; Szwed H
    Kardiol Pol; 2008 Oct; 66(10):1050-8; discussion 1059-60. PubMed ID: 19006026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter-defibrillators in patients with hypertrophic cardiomyopathy -- dilemmas and difficulties.
    Przybylski A; Małecka L; Pytkowski M; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Ruzyłło W; Szwed H
    Kardiol Pol; 2005 Oct; 63(4):391-7; discussion 398. PubMed ID: 16273479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical functioning and mental well-being in association with health outcome in patients enrolled in the Multicenter Automatic Defibrillator Implantation Trial II.
    Piotrowicz K; Noyes K; Lyness JM; McNitt S; Andrews ML; Dick A; Hall WJ; Moss AJ; Zareba W
    Eur Heart J; 2007 Mar; 28(5):601-7. PubMed ID: 17296625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resource loss predicts depression and anxiety among patients treated with an implantable cardioverter defibrillator.
    Luyster FS; Hughes JW; Waechter D; Josephson R
    Psychosom Med; 2006; 68(5):794-800. PubMed ID: 17012535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
    Ellenbogen KA; Levine JH; Berger RD; Daubert JP; Winters SL; Greenstein E; Shalaby A; Schaechter A; Subacius H; Kadish A;
    Circulation; 2006 Feb; 113(6):776-82. PubMed ID: 16461817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock.
    Mishkin JD; Saxonhouse SJ; Woo GW; Burkart TA; Miles WM; Conti JB; Schofield RS; Sears SF; Aranda JM
    J Am Coll Cardiol; 2009 Nov; 54(22):1993-2000. PubMed ID: 19926003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
    Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
    J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Device implant technique and consideration of body image: specific procedures for implantable cardioverter defibrillators in female patients.
    Sowell LV; Kuhl EA; Sears SF; Klodell CT; Conti JB
    J Womens Health (Larchmt); 2006 Sep; 15(7):830-5. PubMed ID: 16999638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Italian Implantable Cardioverter-Defibrillator Registry. A survey of the national activity during the years 2001-2003.
    Proclemer A; Ghidina M; Cicuttini G; Gregori D; Fioretti PM
    Ital Heart J; 2005 Mar; 6(3):272-80. PubMed ID: 15875520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator.
    Korte T; Köditz H; Niehaus M; Paul T; Tebbenjohanns J
    Pacing Clin Electrophysiol; 2004 Jul; 27(7):924-32. PubMed ID: 15271011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.